Aileron Therapeutics, Inc. (ALRN) Financials

ALRN Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 12.8 million 1.6 million
2023-06-30 14.0 million 1.2 million
2023-03-31 17.2 million 2.9 million
2022-12-31 22.0 million 3.4 million

ALRN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -1.6 million 229000
2023-06-30 -3.1 million 300000
2023-03-31 -4.7 million 391000
2022-12-31 -4.4 million 424000

ALRN Net Income

No data available :(

ALRN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 12.1 million - -
2023-06-30 13.7 million - -
2023-03-31 16.7 million - -
2022-12-31 21.2 million - 33000

ALRN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 4.5 million
2023-06-30 4.5 million
2023-03-31 4.5 million
2022-12-31 4.5 million

ALRN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 22000 2.0 million -
2023-06-30 - 187000 1.9 million -
2023-03-31 - 1.8 million 2.2 million -
2022-12-31 - 2.4 million 2.3 million -

ALRN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 12000
2023-06-30 - 12000
2023-03-31 - 43000
2022-12-31 - 43000

ALRN

Price: $3.76

52 week price:
1.01
7.12

Earnings Per Share: -2.85 USD

P/E Ratio: -1.64

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 28786

Ebitda: -6.4 million

Market Capitalization: 26.1 million

Links: